CAS: 1346598-22-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Belotecan-d7 HCl REF: 4Z-I-1846CAS: | - - - | To inquire | Tue 28 May 24 |
 | Belotecan-d7 Hydrochloride (>90%) REF: TR-B131302CAS: 1346598-22-8 | >90% | 253.00 €~1,663.00 € | Wed 29 May 24 |
 | Belotecan-d7 hydrochloride REF: 3D-WDC59822CAS: 1346598-22-8 | Min. 95% | To inquire | Tue 02 Jul 24 |
Ref: 4Z-I-1846
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 May 2024
Belotecan-d7 Hydrochloride (>90%)
Controlled ProductCAS:1346598-22-8
Applications Labelled Belotecan (B131300). A novel camptothecin-derivative anti-tumor agent. CKD-602-related toxicities induced by IV infusion …
Formula:
C25H21D7ClN3O4
Purity:
>90%
Color and Shape:
Neat
Molecular weight:
477.0
Ref: TR-B131302
| 1mg | 253.00 € | |
| 5mg | 1,035.00 € | |
| 10mg | 1,663.00 € |
Estimated delivery in United States, on Wednesday 29 May 2024
Belotecan-d7 hydrochloride
CAS:1346598-22-8
Please enquire for more information about Belotecan-d7 hydrochloride including the price, delivery time and more …
Formula:
C25H28ClN3O4
Purity:
Min. 95%
Molecular weight:
477 g/mol
Ref: 3D-WDC59822
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
